JP2016539112A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539112A5
JP2016539112A5 JP2016532105A JP2016532105A JP2016539112A5 JP 2016539112 A5 JP2016539112 A5 JP 2016539112A5 JP 2016532105 A JP2016532105 A JP 2016532105A JP 2016532105 A JP2016532105 A JP 2016532105A JP 2016539112 A5 JP2016539112 A5 JP 2016539112A5
Authority
JP
Japan
Prior art keywords
composition
pharmaceutically acceptable
acceptable salt
shellac
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016532105A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016539112A (ja
JP6401270B2 (ja
Filing date
Publication date
Priority claimed from IT001906A external-priority patent/ITMI20131906A1/it
Application filed filed Critical
Publication of JP2016539112A publication Critical patent/JP2016539112A/ja
Publication of JP2016539112A5 publication Critical patent/JP2016539112A5/ja
Application granted granted Critical
Publication of JP6401270B2 publication Critical patent/JP6401270B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016532105A 2013-11-18 2014-11-06 徐放性固体経口組成物 Active JP6401270B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITMI2013A001906 2013-11-18
IT001906A ITMI20131906A1 (it) 2013-11-18 2013-11-18 Composizioni solide orali a lento rilascio
US201461989645P 2014-05-07 2014-05-07
US61/989,645 2014-05-07
PCT/IB2014/065852 WO2015071806A1 (en) 2013-11-18 2014-11-06 Slow-release solid oral compositions

Publications (3)

Publication Number Publication Date
JP2016539112A JP2016539112A (ja) 2016-12-15
JP2016539112A5 true JP2016539112A5 (enExample) 2017-03-16
JP6401270B2 JP6401270B2 (ja) 2018-10-10

Family

ID=49780196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016532105A Active JP6401270B2 (ja) 2013-11-18 2014-11-06 徐放性固体経口組成物

Country Status (26)

Country Link
US (1) US10702482B2 (enExample)
EP (1) EP3071191B1 (enExample)
JP (1) JP6401270B2 (enExample)
KR (1) KR102224087B1 (enExample)
CN (1) CN105764493B (enExample)
AU (1) AU2014349782B2 (enExample)
BR (1) BR112016011142B1 (enExample)
CA (1) CA2929426C (enExample)
DK (1) DK3071191T3 (enExample)
EA (1) EA039558B1 (enExample)
ES (1) ES2908924T3 (enExample)
GE (1) GEP20186884B (enExample)
HR (1) HRP20220271T1 (enExample)
HU (1) HUE058086T2 (enExample)
IL (1) IL245167B (enExample)
IT (1) ITMI20131906A1 (enExample)
LT (1) LT3071191T (enExample)
MX (1) MX367664B (enExample)
NZ (1) NZ719000A (enExample)
PH (1) PH12016500693A1 (enExample)
PL (1) PL3071191T3 (enExample)
PT (1) PT3071191T (enExample)
RS (1) RS62916B1 (enExample)
UA (1) UA119856C2 (enExample)
WO (1) WO2015071806A1 (enExample)
ZA (1) ZA201602659B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700074957A1 (it) * 2017-07-04 2019-01-04 Gnosis Spa Sale di (ss)-adenosil metionina con inositolo esafosfato e procedimento per ottenerlo
CN109939077B (zh) * 2017-12-04 2022-07-22 深圳奥萨制药有限公司 一种含有5-甲基四氢叶酸的控释制剂
CN111990674B (zh) * 2020-01-14 2021-07-02 青岛圣邦健康食品有限公司 肠溶包衣材料及其制备方法和肠溶制品
IT202000006127A1 (it) * 2020-03-23 2021-09-23 Fmc S R L Formulazione farmaceutica, dietetica e/o alimentare a base ademetionina e processo di realizzazione di detta formulazione
IT202300007692A1 (it) * 2023-04-19 2024-10-19 Vifra S R L Formulazione farmaceutica, dietetica e/o alimentare a base ademetionina e processo di realizzazione di detta formulazione

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200589B (it) * 1985-02-14 1989-01-27 Gibipharma Spa Derivati naturali attivita farmagologica
ITMI20012462A1 (it) * 2001-11-22 2003-05-22 Gnosis Srl Processo per la preparazione di compresse comprendenti s-adenosilmetionina
US20050181047A1 (en) * 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements
JP2008519071A (ja) 2004-11-05 2008-06-05 ファーブル−クレイマー・ホールディングス・インコーポレイテッド ゲピロンの高用量徐放性製剤
ITMI20060629A1 (it) * 2006-03-31 2007-10-01 Daniele Giovannone Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
US20090088404A1 (en) 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
KR20070093972A (ko) * 2007-06-05 2007-09-19 파브르-크래머 홀딩스. 인크 게피론의 고용량 서방성 제제
US7947662B2 (en) * 2008-02-20 2011-05-24 Gnosis S.P.A. Folates, compositions and uses thereof
US20110027342A1 (en) 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
IT1401146B1 (it) * 2010-07-27 2013-07-12 Gnosis Spa Composizione comprendente shellac e/o un suo sale e sodio amido glicolato

Similar Documents

Publication Publication Date Title
JP2016539112A5 (enExample)
JO3675B1 (ar) مشتقات هيدروكسي إستر جديدة،عملية لتحضيرها وتركيبات صيدلية تحتوي عليها
SA517390586B1 (ar) مشتقات حمض هيدروكسي جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها
MD20140073A2 (en) New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
TN2017000524A1 (en) New bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them
PH12017502266B1 (en) New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them
MD4490B1 (ro) Noi compuşi de indolizină, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin
MY196328A (en) New (Hetero)Aryl-Substituted-Piperidinyl Derivatives, A Process For Their Preparation And Pharmaceutical Compositions Containing Them
IL292465B2 (en) Neuroactive compounds and methods of use thereof
JP2014218522A5 (enExample)
IL217052A0 (en) Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them
EA201891267A1 (ru) Фармацевтическая композиция, содержащая действенный ингибитор urat1
AR105203A1 (es) Formulación oral sólida que contiene irinotecán y método de preparación de la misma
ZA201802312B (en) A group of compounds used for the treatment or prevention of hyperuricemia or gout
SI2729130T1 (en) Combined formulations of darunavir
HK1225712A1 (zh) 作爲溶血磷脂酸受体拮抗剂的酰胺衍生物
HRP20220271T1 (hr) Čvrsti oralni pripravci sa sporim otpuštanjem
EA200901146A1 (ru) Твердые лекарственные формы, содержащие алискирен и его фармацевтически приемлемые соли
WO2012113850A3 (en) (PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR
BR112017005362A2 (pt) composição, forma de dosagem sólida oral, processo para preparação de grânulos efervescentes porosos, processador de parafuso duplo, e, grânulos efervescentes porosos.
JP2016515550A5 (enExample)
JP2015120758A5 (enExample)
IL262494A (en) A pharmaceutical combination preparation containing Ivacaptor and Lomaceptor complex compositions, their salts and derivatives, a process for their preparation and pharmaceutical preparations containing them
HRP20220234T1 (hr) Kristalni oblici
JP2017008001A5 (enExample)